1. Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome. (3rd April 2018) Authors: Christensen, Michael Cronquist; Munro, Vicki Journal: Current medical research and opinion Issue: Volume 34:Number 4(2018) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study. (March 2023) Authors: Almeida, Susana S; Christensen, Michael Cronquist; Simonsen, Kenneth; Adair, Michael Journal: Journal of psychopharmacology Issue: Volume 37:Number 3(2023) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effectiveness of vortioxetine in patients with major depressive disorder comorbid with generalized anxiety disorder: Results of the RECONNECT study. (May 2022) Authors: Christensen, Michael Cronquist; Schmidt, Simon; Grande, Iria Journal: Journal of psychopharmacology Issue: Volume 36:Number 5(2022) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effects of vortioxetine on functional capacity across different levels of functional impairment in patients with major depressive disorder: a University of California, San Diego Performance-based Skills Assessment (UPSA) analysis. (2nd January 2020) Authors: Jacobson, William; Zhong, Wei; Nomikos, George G.; Christensen, Michael Cronquist; Kurre Olsen, Christina; Harvey, Philip D. Journal: Current medical research and opinion Issue: Volume 36:Number 1(2020) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of vortioxetine in working patients with generalized anxiety disorder. (30th October 2017) Authors: Christensen, Michael Cronquist; Loft, Henrik; Florea, Ioana; McIntyre, Roger S. Journal: CNS spectrums Issue: Volume 24:Number 2(2019) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of vortioxetine in working patients with generalized anxiety disorder– ERRATUM. (8th June 2018) Authors: Christensen, Michael Cronquist; Loft, Henrik; Florea, Ioana; McIntyre, Roger S. Journal: CNS spectrums Issue: Volume 24:Number 2(2019) Page Start: 275 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy of vortioxetine on the physical symptoms of major depressive disorder. (October 2018) Authors: Christensen, Michael Cronquist; Florea, Ioana; Lindsten, Annika; Baldwin, David S Journal: Journal of psychopharmacology Issue: Volume 32:Number 10(2018) Page Start: 1086 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Vortioxetine 20 mg/day in patients with major depressive disorder: updated analysis of efficacy, safety, and optimal timing of dose adjustment. (18th February 2023) Authors: Christensen, Michael Cronquist; McIntyre, Roger S.; Florea, Ioana; Loft, Henrik; Fagiolini, Andrea Journal: CNS spectrums Issue: Volume 28:Number 1(2023) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗